M. Stabl
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 2%
- Electroconvulsive Therapy Studies
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
Papers in
- Pharmacology 19
- Treatment of Major Depression 18
- Pharmacological Effects of Natural Compounds 1
-
- Electroconvulsive Therapy Studies 11
- Bipolar Disorder and Treatment 5
- Attention Deficit Hyperactivity Disorder 5
- Co-authors
- Jules Angst (5 shared papers)R. Amrein (9 shared papers)W. Schmid‐Burgk (5 shared papers)Márcio Versiani (2 shared papers)Kathleen Bizière (2 shared papers)G. Hebenstreit (2 shared papers)Roman Fischbach (1 shared paper)Ulf Baumhackl (2 shared papers)
- Journals
- International Clinical Psychopharmacology (3 papers)Psychopharmacology (3 papers)Acta Psychiatrica Scandinavica (2 papers)Journal of Clinical Psychopharmacology (2 papers)The British Journal of Psychiatry (2 papers)
- Partner nations
- SwitzerlandBrazilUnited Kingdom
In The Last Decade
M. Stabl
23 papers receiving 645 citations
Peers
Comparison fields: 5 of 67
- Biological Psychiatry 69
- Psychiatry and Mental health 378
- Pharmacology 402
- Experimental and Cognitive Psychology 134
- Cellular and Molecular Neuroscience 110
Countries citing papers authored by M. Stabl
This map shows the geographic impact of M. Stabl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Stabl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Stabl more than expected).
Fields of papers citing papers by M. Stabl
This network shows the impact of papers produced by M. Stabl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Stabl. The network helps show where M. Stabl may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Stabl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 82 | |
| 2 | 1992 | 82 | |
| 3 | 1994 | 51 | |
| 4 | 1995 | 47 | |
| 5 | 1995 | 46 | |
| 6 | 1996 | 45 | |
| 7 | 1990 | 44 | |
| 8 | 1992 | 44 | |
| 9 | 1997 | 41 | |
| 10 | 1993 | 37 | |
| 11 | Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states. | 1989 | 33 |
| 12 | Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale. | 1993 | 29 |
| 13 | 1993 | 28 | |
| 14 | 1997 | 20 | |
| 15 | 1994 | 20 | |
| 16 | Antidepressant drug therapy: associated risks. | 1988 | 18 |
| 17 | 1996 | 14 | |
| 18 | 1995 | 13 | |
| 19 | 1995 | 12 | |
| 20 | 1993 | 12 |
About M. Stabl
M. Stabl is a scholar working on Pharmacology, Psychiatry and Mental health, Biological Psychiatry, Clinical Psychology and Experimental and Cognitive Psychology, having authored 23 papers that have together received 733 indexed citations. Recurring topics across this work include Treatment of Major Depression (18 papers), Electroconvulsive Therapy Studies (11 papers), Bipolar Disorder and Treatment (5 papers), Attention Deficit Hyperactivity Disorder (5 papers), Tryptophan and brain disorders (3 papers), Mental Health Research Topics (2 papers), Pharmacological Effects of Natural Compounds (1 paper) and Child and Adolescent Psychosocial and Emotional Development (1 paper). The work is most often cited by research in Biological Psychiatry (69 citations), Psychiatry and Mental health (378 citations), Pharmacology (402 citations), Experimental and Cognitive Psychology (134 citations) and Cellular and Molecular Neuroscience (110 citations). M. Stabl has collaborated with scholars based in Switzerland, Brazil and United Kingdom. Frequent co-authors include Jules Angst, R. Amrein, W. Schmid‐Burgk, Márcio Versiani, Kathleen Bizière, G. Hebenstreit, Roman Fischbach, Ulf Baumhackl, Jasper Dingemanse and Antônio Egídio Nardi. Their work appears in journals such as International Clinical Psychopharmacology, Psychopharmacology, Acta Psychiatrica Scandinavica, Journal of Clinical Psychopharmacology and The British Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.